April 2014 - Volume 37 - Issue 3
pp: 135-191
Subscribe to eTOC


T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells: Lessons From a Phase I/II Feasibility and Safety Study

Gallot, Géraldine; Vollant, Solène; Saïagh, Soraya; More

Journal of Immunotherapy . 37(3):170-179, April 2014.

A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

Monk, Paul; Lam, Elaine; Mortazavi, Amir; More

Journal of Immunotherapy . 37(3):180-186, April 2014.